Theriva Biologics, Inc.
Theriva Biologics, Inc.
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| SYN-004 Safety and Tolerability in Allo-HCT Subjects | Acute Graft-Versus-Host Reaction Following Bone Marrow Transplant; Prevention of CDI in Adult Patients Being Treated With IV Beta-lactam Antibiotics | Active, not recruiting | Phase 1 / Phase 2 | 2026-03-17 | NCT04692181 |